CN114190544A - Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts - Google Patents
Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts Download PDFInfo
- Publication number
- CN114190544A CN114190544A CN202010909240.9A CN202010909240A CN114190544A CN 114190544 A CN114190544 A CN 114190544A CN 202010909240 A CN202010909240 A CN 202010909240A CN 114190544 A CN114190544 A CN 114190544A
- Authority
- CN
- China
- Prior art keywords
- calcium
- parts
- astronauts
- nutritional preparation
- supplementing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011575 calcium Substances 0.000 title claims abstract description 83
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 83
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 230000001502 supplementing effect Effects 0.000 title claims abstract description 36
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 34
- 239000011707 mineral Substances 0.000 title claims abstract description 34
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 210000000988 bone and bone Anatomy 0.000 title abstract description 18
- 230000037182 bone density Effects 0.000 claims abstract description 32
- 241000208688 Eucommia Species 0.000 claims abstract description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 23
- 235000013336 milk Nutrition 0.000 claims abstract description 21
- 239000008267 milk Substances 0.000 claims abstract description 21
- 210000004080 milk Anatomy 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 229940034055 calcium aspartate Drugs 0.000 claims abstract description 17
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 16
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 238000010521 absorption reaction Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000008280 blood Substances 0.000 claims abstract description 4
- 210000004369 blood Anatomy 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 3
- 102000008186 Collagen Human genes 0.000 claims description 24
- 108010035532 Collagen Proteins 0.000 claims description 24
- 229920001436 collagen Polymers 0.000 claims description 24
- GYUKEMYHXWICKF-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;calcium Chemical compound [Ca].OC(=O)[C@@H](N)CC(O)=O GYUKEMYHXWICKF-DKWTVANSSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229960005261 aspartic acid Drugs 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000007794 irritation Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 2
- 239000000920 calcium hydroxide Substances 0.000 claims description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 claims description 2
- 230000002787 reinforcement Effects 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 2
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- OPSXJNAGCGVGOG-DKWTVANSSA-L Calcium L-aspartate Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CC([O-])=O OPSXJNAGCGVGOG-DKWTVANSSA-L 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 description 8
- 206010006956 Calcium deficiency Diseases 0.000 description 5
- 229940069978 calcium supplement Drugs 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- ZJSJQWDXAYNLNS-UHFFFAOYSA-N (+) pinoresinol-4,4'-di-O-beta-D-glucopyranoside Natural products COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC4C(C(O)C(O)C(CO)O4)O)=CC=3)CO2)=CC=C1OC1OC(CO)C(O)C(O)C1O ZJSJQWDXAYNLNS-UHFFFAOYSA-N 0.000 description 1
- ZJSJQWDXAYNLNS-FUPWJLLWSA-N (2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)CO2)=CC=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZJSJQWDXAYNLNS-FUPWJLLWSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010214 Compression fracture Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of food and health food, and particularly relates to a nutritional preparation for improving bone mineral density and supplementing calcium for astronauts. The main raw materials comprise calcium aspartate (chelated calcium), ossein protein peptide, milk mineral salt, eucommia male flower, and stachyose. The human metabolic theory is used as guidance, the absorption of calcium and other nutrients in the body is promoted, the utilization of tissue cells to the nutrients is improved, the conversion of blood calcium and bone calcium is enhanced, and the effects of increasing bone density and supplementing calcium are achieved. Easy absorption, obvious effect and short acting period, and is especially suitable for special workers such as astronauts.
Description
Technical Field
The invention relates to the technical field of food and health food, in particular to a nutritional preparation for improving bone density of astronauts and supplementing calcium.
Background
Bone density (BMD) is called bone mineral density, is an index of human bone strength, is an important mark of bone quality, reflects osteoporosis degree and predicts important basis of fracture risk. Calcium is the support of the skeleton, and more than 99% of the human body's calcium is present in the skeleton and teeth. After the age of 35, the bone density is gradually reduced, and after the middle-aged, the calcium loss is accelerated, which is a big cause of osteoporosis. Calcium supplementation is a process aimed at increasing calcium intake, but in many osteoporosis, rather than simply lacking calcium, it is the result of supplementing bone density, which is also intended to increase bone density, and in the event of calcium deficiency, calcium is supplemented by calcium supplements. Supplementing magnesium, phosphorus, potassium, vitamin K, vitamin B and the like can form bones and promote the key of bone density.
Calcium cannot be synthesized in the human body and can only be taken from food, but 800 mg of calcium required by the human body per day cannot be met from the ordinary diet at all, and the human body is additionally charged. Calcium deficiency is one of the main causes of senile osteoporosis, however, many aging symptoms of the elderly are caused by osteoporosis, such as systemic osteodynia, particularly senile lumbocrural pain, early hunchback, body movement disorder and the like. Osteoporosis can cause fracture of the elderly, such as lumbar vertebral compression fracture and limb fracture.
In various people in China, the intake of calcium only accounts for 33.9-53.7% of the recommended amount standard of the Chinese society of Nutrition. According to the standard of Chinese resident dietary nutrient reference intakes (Chinese DIRs) passed by the eighth national nutrition conference, the recommended daily calcium intake is 800 mg, and the recommended calcium intake of teenagers and pregnant women is 1200-1500 mg. On the basis of normal diet, each person needs to supplement 400-600 mg of calcium every day, and especially teenagers, pregnant and lying-in women and middle-aged and old people need to supplement proper amount of calcium. Due to the dietary habits of Chinese people, the calcium intake of most people is less than half of the standard amount, and scientific calcium supplement is very important for ensuring the health of Chinese people and preventing various diseases caused by calcium deficiency. China is wide in regions, and the calcium deficiency conditions of different regions are different. The calcium intake of the crowd in the animal husbandry area and the crowd in the area with high soybean product intake is sufficient, the calcium deficiency condition of the urban crowd with more egg and milk intake and the crowd with more edible fishes in the coastal area is not serious, the calcium intake of the crowd in the inland part of areas, particularly the northern rural areas taking the rice and flour vegetables as daily staple food is low, and the daily calcium intake is only about 400 mg. In contrast, oral calcium supplement is an effective calcium supplement method because of insufficient calcium supplement of Chinese food due to dietary habits.
The biological agent of Johnson space center, Paget wittson, in the United states, carried the research group to conduct the "astronauts' risk of developing kidney stones" investigation, selected astronauts who worked continuously in the "peace and number" space station for more than 100 days in 1995-. The results show that under the condition of space weightlessness, the astronaut can form kidney stones very quickly in long-term space life. The investigators confined 12 healthy volunteers to bed for 30 days to induce bone loss in the volunteer's bones. Surprisingly, the method judges the early stage of osteoporosis in one week after the experiment is started, and the result is more excellent than the previous traditional medical scanning result, and the research result is published in the journal of the national academy of sciences of the United states.
Based on the current situation, people working at special posts are more concerned about, especially for astronauts struggling with the Chinese aerospace industry. Space flight is a special professional activity, and has the characteristics of special working environment, highly complex professional skills, difficult flight task and the like. Such occupations require astronauts to have not only a healthy physical constitution and good psychological quality, but also high resistance and pressure resistance to the aerospace environment, as well as profound knowledge and high skills. Therefore, a nutritional preparation for improving bone density and supplementing calcium for astronauts, alleviating adverse effects caused by aerospace environmental factors and maintaining physical and mental health of astronauts is needed.
Disclosure of Invention
The invention provides a nutritional preparation for improving bone mineral density and supplementing calcium for astronauts.
In order to achieve the above object, the embodiment of the present invention provides a nutritional preparation for increasing bone density and supplementing calcium for astronauts, which is characterized in that: comprises main components of calcium aspartate (chelated calcium), milk mineral salt, collagen peptide, stachyose and eucommia male flower.
Further, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized by being prepared from the following main components in parts by weight: 6-9 parts of calcium aspartate (chelated calcium), 4-6 parts of milk mineral salt, 18-21 parts of collagen peptide, 13-16 parts of stachyose and 6-9 parts of eucommia male flower.
Further, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized by being prepared from the following main components in parts by weight: 6 parts of calcium aspartate (chelated calcium), 5 parts of milk mineral salt, 18 parts of collagen peptide, 13 parts of stachyose and 6 parts of eucommia male flower.
Further, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized by being prepared from the following main components in parts by weight: 8 parts of calcium aspartate (chelated calcium), 6 parts of milk mineral salt, 20 parts of collagen peptide, 15 parts of stachyose and 9 parts of eucommia male flower.
The nutritional preparation for improving the bone mineral density and supplementing calcium of astronauts is characterized in that L-aspartic acid and calcium hydroxide are used as main raw materials of the main component, and the main component is a food-grade additive prepared through chelation reaction, so that the nutritional preparation has the characteristics of easiness in absorption, strong penetrability, high bioavailability, no irritation, good stability, no need of reinforcement, stable blood calcium level, good tolerance, increase in bone mineral density and the like.
Further, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized in that milk mineral salt in the main component is a new food raw material approved by national ministry of health 2009, No. 18, and meets the quality requirements of national regulations.
Further, the nutritional preparation for improving the bone density and supplementing calcium of astronauts is characterized in that the main component of the collagen peptide is fresh high-quality animal collagen essence, micromolecule collagen polypeptide which is easy to digest and absorb by human bodies is prepared by a scientific high-temperature and high-pressure boiling method and a modern bio-enzyme engineering technology, and collagen polypeptide essence liquid which is separated, purified and concentrated is refined into collagen powder which is convenient to transport and eat.
Further, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized in that the main component eucommia male flower is purchased from Jiang grass Biotechnology GmbH in Shaanxi, and is produced by water extraction and then concentration at a ratio of 30: 1.
Furthermore, the nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized in that other auxiliary materials are added according to the proportion of the main components to prepare tablets, powder, liquid preparations and other dosage forms.
The invention is used as a nutritional preparation for increasing bone mineral density and supplementing calcium, and has the advantages that: according to the specific embodiment of the invention, the calcium aspartate and the milk mineral salt are organically combined to meet the requirements of different people on calcium, and simultaneously the stachyose is combined to promote the absorption of calcium and other minerals, and then the collagen peptide with the hands is carried to enhance the bone mineral density, so that the eucommia male flowers can enhance the absorption, utilization and excretion, and the effects of increasing the bone mineral density and supplementing calcium are achieved.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention provides a nutritional preparation for improving bone mineral density and supplementing calcium for astronauts, which is characterized by comprising the following components in parts by weight: comprises main components of calcium aspartate (chelated calcium), milk mineral salt, collagen peptide, stachyose and eucommia male flower. The nutritional preparation for improving the bone density of astronauts and supplementing calcium is prepared from the following main components in parts by weight: 6-9 parts of calcium aspartate (chelated calcium), 4-6 parts of milk mineral salt, 18-21 parts of collagen peptide, 13-16 parts of stachyose and 6-9 parts of eucommia male flower.
Calcium aspartate (chelated calcium) is used as a calcium source and is implemented according to the relevant regulations of the food nutrition enhancer use health standard (the implementation standard GB29226-2012 made by the participation of Saibetai) in China, can stably enter the small intestine through the stomach and be absorbed by the human body, and the molecular structure of the calcium aspartate is similar to dipeptide protein calcium in natural food and is easy to be absorbed by intestinal tracts.
The milk mineral salt is prepared from whey as raw material by removing protein, lactose, etc., and is a nutritional supplement easy to be absorbed by human body. The milk mineral salt is a new resource food, contains more minerals, mainly calcium and phosphorus, is close to the composition of human skeleton teeth, has better calcium supplementing effect due to reasonable calcium-phosphorus ratio, has small irritation to intestines and stomach, can not reverse the calcium supplementing effect, can still maintain the increased bone density even after the milk mineral salt is stopped to be supplemented for three years, and can gradually disappear after the inorganic calcium is stopped to be supplemented.
The collagen peptide is a structural protein of extracellular matrix, is a main component in animal connective tissue, is formed with the tissue, matures, transfers intercellular information, promotes the generation of osteocyte, accelerates the development of bones, improves the firmness of the bones, relieves joint pain, improves the loss of proteoglycan in articular cartilage, prevents osteoporosis, increases bone density and the like, is used as a small molecular peptide, has lower molecular weight and better digestion and absorption, can be directly absorbed by intestinal tracts, enters blood and reaches various parts of the body such as skin, liver, kidney and the like.
Stachyose is functional oligosaccharide, can replace metal ions, thereby promoting the absorption of mineral substances such as calcium, magnesium and the like, has very obvious proliferation effect on beneficial flora such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of a human body, can quickly improve the environment in the digestive tract of the human body and adjust the balance of microecological flora.
The eucommia male flower contains more than 60 effective plant components, such as lignins, iridoids, phenylpropanoid active substances (such as geniposide acid, chlorogenic acid and aucubin), pinoresinol diglucoside, flavone, alkaloid, amino acid, polysaccharide, mineral elements Zn, Mn, Cu, Fe, Ca, P, B, Mg, K and the like, wherein the content of the amino acid reaches 21.47%, the content of the calcium reaches 0.92%, the content of the zinc reaches 51Mg/100g, which is 1.8 times and 5.2 times of that of eucommia leaves respectively, the effective components are most comprehensive and higher, the eucommia male flower integrates all eucommia, can be said to have all health-care effects of the plant eucommia, and has particularly obvious effects on 'liver strengthening, kidney tonifying, bowel relaxing, sleep improving and three-high'. The Shennong Ben Cao Jing records that eucommia bark is mainly used for treating lumbar pain, strengthening the middle-jiao, benefiting vital essence and strengthening bones and muscles.
The nutritional preparation for improving the bone density and supplementing calcium of the astronaut is characterized by being prepared from the following main components in parts by weight: 6 parts of calcium aspartate (chelated calcium), 5 parts of milk mineral salt, 18 parts of collagen peptide, 13 parts of stachyose and 6 parts of eucommia male flower.
The nutritional preparation for improving the bone density and supplementing calcium of the astronaut is characterized by being prepared from the following main components in parts by weight: 8 parts of calcium aspartate (chelated calcium), 6 parts of milk mineral salt, 20 parts of collagen peptide, 15 parts of stachyose and 9 parts of eucommia male flower.
The nutritional preparation for improving the bone density of astronauts and supplementing calcium is characterized in that other auxiliary materials are added according to the proportion of the main components to prepare tablets, powder, liquid preparations and other dosage forms.
The calcium aspartate (chelated calcium), milk mineral salt, ossein peptide, stachyose and eucommia male flower are reasonably matched and scientifically matched, and the human metabolic theory is used as guidance, so that the requirements for improving the bone density of astronauts and supplementing calcium are met.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (9)
1. A nutritional preparation for improving bone density and supplementing calcium of astronauts is characterized in that: comprises main components of calcium aspartate (chelated calcium), milk mineral salt, collagen peptide, stachyose and eucommia male flower.
2. The nutritional preparation for increasing the bone density and supplementing calcium of astronauts according to claim 1, which is prepared from the following main components in parts by weight: 6-9 parts of calcium aspartate (chelated calcium), 4-6 parts of milk mineral salt, 18-21 parts of collagen peptide, 13-16 parts of stachyose and 6-9 parts of eucommia male flower.
3. The nutritional preparation for increasing the bone density and supplementing calcium of astronauts according to claim 2, which is prepared from the following main components in parts by weight: 6 parts of calcium aspartate (chelated calcium), 5 parts of milk mineral salt, 18 parts of collagen peptide, 13 parts of stachyose and 6 parts of eucommia male flower.
4. The nutritional preparation for increasing the bone density and supplementing calcium of astronauts according to claim 2, which is prepared from the following main components in parts by weight: 8 parts of calcium aspartate (chelated calcium), 6 parts of milk mineral salt, 20 parts of collagen peptide, 15 parts of stachyose and 9 parts of eucommia male flower.
5. The nutritional preparation according to any one of claims 1 to 4, wherein aspartic acid (chelated calcium), also called amino acid chelated calcium, in the main component is a food grade additive prepared by chelating reaction with L-aspartic acid and calcium hydroxide as main raw materials, and has the characteristics of easy absorption, strong penetrability, high bioavailability, no irritation, good stability, no need of reinforcement, stable blood calcium level, good tolerance, increased bone density and the like.
6. The nutritional preparation for improving the bone density and supplementing calcium of astronauts according to any one of claims 1 to 4, wherein the milk mineral salt in the main component is a new food raw material approved by national Ministry of health 2009, No. 18, and meets the quality requirements of national regulations.
7. The nutritional preparation for increasing the bone density and supplementing calcium of astronauts according to any one of claims 1 to 4, wherein the main component of the collagen peptide is selected from fresh high-quality animal collagen essence, small molecular collagen polypeptide which is easy to be digested and absorbed by human body is prepared by scientific high-temperature and high-pressure boiling method and modern bio-enzyme engineering technology, and the collagen peptide essence is separated, purified and concentrated to be refined into collagen powder which is convenient to transport and eat.
8. The nutritional preparation for improving the bone density and supplementing calcium of astronauts according to any one of claims 1 to 4, wherein the main component eucommia male flower is purchased from Jiang He Biotechnology GmbH, Shaanxi, and is produced by extracting with water and then concentrating at a ratio of 30: 1.
9. The nutritional preparation for increasing the bone density and supplementing calcium of astronauts according to any one of claims 1 to 4, wherein other auxiliary materials are added according to the proportion of each main component to prepare tablets, powder, liquid preparations and other dosage forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010909240.9A CN114190544A (en) | 2020-09-02 | 2020-09-02 | Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010909240.9A CN114190544A (en) | 2020-09-02 | 2020-09-02 | Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114190544A true CN114190544A (en) | 2022-03-18 |
Family
ID=80644333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010909240.9A Pending CN114190544A (en) | 2020-09-02 | 2020-09-02 | Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114190544A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1785427A (en) * | 2005-11-21 | 2006-06-14 | 陈斌 | Compound calcium preparation for astronaut |
| CN107625124A (en) * | 2017-09-29 | 2018-01-26 | 武汉华士特工业生物技术开发有限公司 | A kind of functional food for increasing bone density and preparation method thereof |
| CN110074250A (en) * | 2019-03-29 | 2019-08-02 | 广东澳思瑞雅健康美容生物科技有限公司 | A kind of formula and preparation method of supplement skeleton nutrition and improvement skeletal function |
| CN110269243A (en) * | 2018-03-17 | 2019-09-24 | 北京神飞航天应用技术研究院 | A kind of dedicated raising bone density nutritional preparation of spacefarer |
-
2020
- 2020-09-02 CN CN202010909240.9A patent/CN114190544A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1785427A (en) * | 2005-11-21 | 2006-06-14 | 陈斌 | Compound calcium preparation for astronaut |
| CN107625124A (en) * | 2017-09-29 | 2018-01-26 | 武汉华士特工业生物技术开发有限公司 | A kind of functional food for increasing bone density and preparation method thereof |
| CN110269243A (en) * | 2018-03-17 | 2019-09-24 | 北京神飞航天应用技术研究院 | A kind of dedicated raising bone density nutritional preparation of spacefarer |
| CN110074250A (en) * | 2019-03-29 | 2019-08-02 | 广东澳思瑞雅健康美容生物科技有限公司 | A kind of formula and preparation method of supplement skeleton nutrition and improvement skeletal function |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN102754753A (en) | Feed for improving growth performances of broiler chickens and preparation method thereof | |
| CN102077945B (en) | Special dietary seafood for postabortal and postpartum women | |
| CN109007857A (en) | Improve the food formula of special diet and preparation method thereof of mankind spermatozoon quality | |
| CN102077937B (en) | Special dietary seafood special for young and middle-aged women | |
| CN112772813A (en) | Compound peptide solid beverage capable of improving immunity and relieving fatigue and preparation method thereof | |
| CN104172147A (en) | Se-enriched natural nutritional food and preparation method thereof | |
| CN102077944B (en) | Marine special dietary food special for prostate patient | |
| CN105995135A (en) | Chicken feed | |
| CN107495387A (en) | A kind of ocean polypeptide spy's dietary seafood as sports tonica | |
| CN104824674A (en) | Nutrient health-care food for preventing and treating alopecia | |
| CN102172288B (en) | Osteocalcin noodles and making method thereof | |
| CN101103816B (en) | Sea-buckthorn nutrient food additive and flour composition containing thereof | |
| CN1049097C (en) | Super concentrated fodder for ruminant | |
| CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN110604295A (en) | Composite bone peptide and preparation method thereof | |
| CN114190544A (en) | Nutritional preparation for improving bone mineral density and supplementing calcium for astronauts | |
| CN101991110A (en) | Wild ganoderma lucidum food | |
| CN113598377A (en) | Composition for improving anemia, functional food thereof, preparation method and application | |
| CN1191116A (en) | Oral snake liquid | |
| CN108402462B (en) | Composition and product for relieving physical fatigue and enhancing immunity | |
| CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
| CN102077941B (en) | Special dietary seafood special for climacteric women | |
| KR19990080441A (en) | Health supplement composition for growth | |
| CN111000037A (en) | High-selenium auxiliary anti-cancer goat milk and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |